Pet Cancer Therapeutics Global Market Report 2024

Description

“Pet Cancer Therapeutics Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pet cancer therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pet cancer therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pet cancer therapeutics market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Cancer Type: Melanoma; Mast Cell Cancer; Lymphoma; Mammary And Squamous Cell Cancer
2) By Species: Dogs; Cats; Other Species
3) By Therapy: Chemotherapy; Radiation Therapy; Immunotherapy; TomoTherapy; Other Therapies
4) By End User: Veterinary Hospitals; Clinical Pharmacies; Retail Pharmacies; Online Pharmacies; Other End Users
Companies Mentioned: AB Science; Boehringer Ingelheim GmbH; Elanco Animal Health; ELIAS Animal Health; Zoetis Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Pet cancer therapeutics involve the use of various treatments and medications to manage or cure cancer in pets. The choice of therapeutics depends on several factors such as the type and stage of cancer, as well as the pet's age and overall health.

The main types of pet cancer therapeutics are tailored to specific cancer types, including melanoma, mast cell cancer, lymphoma, and mammary and squamous cell cancer. Melanoma is a type of cancer that originates from pigment-producing cells called melanocytes. These therapeutics can be administered through various routes, including oral and injection methods, tailored for dogs, cats, and other animals. Different therapies employed in pet cancer treatment include chemotherapy, radiation therapy, immunotherapy, tomo therapy, and others. These therapies are utilized by veterinary hospitals, clinical pharmacies, retail pharmacies, online pharmacies, and other healthcare facilities focused on pet health.

The pet cancer therapeutics market research report is one of a series of new reports from The Business Research Company that provides pet cancer therapeutics market statistics, including pet cancer therapeutics industry global market size, regional shares, competitors with a pet cancer therapeutics market share, detailed pet cancer therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the pet cancer therapeutics industry. This pet cancer therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pet cancer therapeutics market size has grown rapidly in recent years. It will grow from $0.35 billion in 2023 to $0.39 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The growth observed in the historical period can be attributed to several factors, including the rise in pet ownership, advancements in veterinary medicine, increased awareness of pet health, the humanization of pets, and the expansion of veterinary services. These factors collectively contributed to an increased focus on the health and well-being of pets, leading to growth in the pet healthcare industry, including pet cancer therapeutics.

The pet cancer therapeutics market size is expected to see rapid growth in the next few years. It will grow to $0.59 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The anticipated growth in the forecast period can be attributed to factors such as the growing aging pet population, advancements in cancer treatment for pets, the rise of veterinary oncology services, increased adoption of pet insurance and healthcare plans, and the global expansion of pet care services. Major trends expected in the forecast period include a rise in nutraceuticals and integrative therapies for pet cancer treatment, increased availability of targeted diagnostic tests, collaboration between veterinary and human oncology for cross-disciplinary insights, the introduction of novel chemotherapeutic agents tailored for pets, and a growing awareness with increased education for pet owners about cancer in pets and available treatment options.

The anticipated growth in pet healthcare expenditure is set to drive the expansion of the pet cancer therapeutics market. Pet healthcare expenditure encompasses the funds allocated for veterinary services, medications, and other healthcare-related costs for pets. The rising trend of pet owners' willingness to invest in their pets' well-being is reflected in the increased expenditure on pet healthcare, leading to a higher demand for pet cancer therapeutics. For example, the North American Pet Health Insurance Association's (NAPHIA) 2023 State of the Industry Report revealed a 22% increase in the total number of insured pets in the U.S. by the end of 2022, reaching 4.8 million, compared to 2021. This surge in pet healthcare expenditure is a driving force for the pet cancer therapeutics market.

The growth of the pet cancer therapeutics market is expected to be propelled by the increasing prevalence of pet cancer. Pet cancer involves abnormal and uncontrolled cell growth in domesticated animals, leading to tumor formation. The rising incidence of pet cancer is attributed to environmental toxins, pollutants, and genetic and lifestyle factors. Consequently, there is an escalating demand for advanced and effective cancer therapeutics for pets. According to the Veterinary Cancer Society's (VCS) 2022 predictions, approximately 1 in 4 dogs is diagnosed with cancer during their lifetime, with cancer being a primary cause of death among older pets. Additionally, the National Cancer Institute anticipates approximately 6 million new cancer cases in pets annually, with a projected increase in the coming years. The increasing prevalence of pet cancer is poised to drive the growth of the pet cancer therapeutics market.

Technological advancement emerges as a prominent trend gaining popularity in the pet cancer therapeutics market. Major players are dedicating efforts to develop innovative technologies to enhance their market position. For instance, in May 2021, PetDx, a U.S.-based biotech company in the animal health industry, introduced OncoK9, a cutting-edge blood-based multi-cancer early detection (MCED) test designed specifically for dogs. This technology employs advanced genomic analysis, leveraging next-generation sequencing (NGS) to provide enhanced capabilities for cancer detection.

Strategic partnerships are a significant approach adopted by major companies in the pet cancer therapeutics market to achieve superior disease control. This collaborative strategy involves leveraging each other's strengths and resources to attain mutual benefits and success. One such collaboration occurred in June 2022, when Germany-based pharmaceutical company Boehringer Ingelheim partnered with U.S.-based biopharmaceutical company CarthroniX. The collaboration focuses on identifying new small molecules to target cancers in dogs, potentially offering superior disease control. CarthroniX will supply the small molecules for evaluation by Boehringer Ingelheim, emphasizing their commitment to advancing oncology research in animal health and exploring new therapeutic options for the treatment of canine cancer.

In June 2021, Elanco, a U.S.-based animal health company, acquired Kindred Biosciences for an undisclosed amount. This strategic acquisition positions Elanco to expand its portfolio of animal health products and gain access to new technologies and development platforms. Kindred Biosciences, a U.S.-based biopharmaceutical company, specializes in developing innovative treatments for pets.

Major companies operating in the pet cancer therapeutics market report are AB Science, Boehringer Ingelheim GmbH, Elanco Animal Health, ELIAS Animal Health, Zoetis Inc., Aratana Therapeutics Inc., Anivive Lifesciences Inc., QBiotics Group Ltd., Regeneus Ltd., VetDC Inc., PetCure Oncology at Veterinary Radiosurgery and Imaging Center, Karyopharm Therapeutics Inc., Torigen Pharmaceuticals Inc., virology and bacteriology, Nippon Zenyaku Kogyo Co. Ltd., Vivesto AB, Dechra Pharmaceuticals plc, Elekta Medical Systems India Pvt. Ltd., Norbrook Laboratories Ltd., AdvaVet Inc., Merial Animal Health Ltd., Oasmia Pharmaceuticals AB, Zenoaq Co. Ltd., Rhizen Pharmaceuticals SA, Morphogenesis Inc., Pfizer Inc., Sumitomo Pharma Animal Health Co., Vetivax, CarthroniX Inc

North America was the largest region in the pet cancer therapeutics market in 2023. The regions covered in the pet cancer therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pet cancer therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pet cancer therapeutics market consists of revenues earned by entities by surgery and palliative care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r11230

1. Executive Summary

2. Pet Cancer Therapeutics Market Characteristics

3. Pet Cancer Therapeutics Market Trends And Strategies

4. Pet Cancer Therapeutics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Pet Cancer Therapeutics Market Size and Growth

5.1. Global Pet Cancer Therapeutics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Pet Cancer Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Pet Cancer Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pet Cancer Therapeutics Market Segmentation

6.1. Global Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Melanoma
Mast Cell Cancer
Lymphoma
Mammary And Squamous Cell Cancer
6.2. Global Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Dogs
Cats
Other Species
6.3. Global Pet Cancer Therapeutics Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chemotherapy
Radiation Therapy
Immunotherapy
TomoTherapy
Other Therapies
6.4. Global Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Veterinary Hospitals
Clinical Pharmacies
Retail Pharmacies
Online Pharmacies
Other End Users

7. Pet Cancer Therapeutics Market Regional And Country Analysis

7.1. Global Pet Cancer Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pet Cancer Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pet Cancer Therapeutics Market

8.1. Asia-Pacific Pet Cancer Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pet Cancer Therapeutics Market

9.1. China Pet Cancer Therapeutics Market Overview
9.2. China Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pet Cancer Therapeutics Market

10.1. India Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pet Cancer Therapeutics Market

11.1. Japan Pet Cancer Therapeutics Market Overview
11.2. Japan Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pet Cancer Therapeutics Market

12.1. Australia Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pet Cancer Therapeutics Market

13.1. Indonesia Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pet Cancer Therapeutics Market

14.1. South Korea Pet Cancer Therapeutics Market Overview
14.2. South Korea Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pet Cancer Therapeutics Market

15.1. Western Europe Pet Cancer Therapeutics Market Overview
15.2. Western Europe Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pet Cancer Therapeutics Market

16.1. UK Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pet Cancer Therapeutics Market

17.1. Germany Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pet Cancer Therapeutics Market

18.1. France Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pet Cancer Therapeutics Market

19.1. Italy Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pet Cancer Therapeutics Market

20.1. Spain Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pet Cancer Therapeutics Market

21.1. Eastern Europe Pet Cancer Therapeutics Market Overview
21.2. Eastern Europe Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pet Cancer Therapeutics Market

22.1. Russia Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pet Cancer Therapeutics Market

23.1. North America Pet Cancer Therapeutics Market Overview
23.2. North America Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pet Cancer Therapeutics Market

24.1. USA Pet Cancer Therapeutics Market Overview
24.2. USA Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pet Cancer Therapeutics Market

25.1. Canada Pet Cancer Therapeutics Market Overview
25.2. Canada Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pet Cancer Therapeutics Market

26.1. South America Pet Cancer Therapeutics Market Overview
26.2. South America Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pet Cancer Therapeutics Market

27.1. Brazil Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pet Cancer Therapeutics Market

28.1. Middle East Pet Cancer Therapeutics Market Overview
28.2. Middle East Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pet Cancer Therapeutics Market

29.1. Africa Pet Cancer Therapeutics Market Overview
29.2. Africa Pet Cancer Therapeutics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pet Cancer Therapeutics Market, Segmentation By Species, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pet Cancer Therapeutics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pet Cancer Therapeutics Market Competitive Landscape And Company Profiles

30.1. Pet Cancer Therapeutics Market Competitive Landscape
30.2. Pet Cancer Therapeutics Market Company Profiles
- 30.2.1. AB Science
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Boehringer Ingelheim GmbH
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Elanco Animal Health
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. ELIAS Animal Health
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Zoetis Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Pet Cancer Therapeutics Market Competitive Benchmarking

32. Global Pet Cancer Therapeutics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Pet Cancer Therapeutics Market

34. Pet Cancer Therapeutics Market Future Outlook and Potential Analysis

34.1 Pet Cancer Therapeutics Market In 2028 - Countries Offering Most New Opportunities
34.2 Pet Cancer Therapeutics Market In 2028 - Segments Offering Most New Opportunities
34.3 Pet Cancer Therapeutics Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer